Lunate Capital
Latest statistics and disclosures from Lunate Capital's latest quarterly 13F-HR filing:
- Top 5 stock holdings are RVMD, SAIL, Figure Technology Solutio, LINE, NMRA, and represent 99.94% of Lunate Capital's stock portfolio.
- Added to shares of these 1 stock: Figure Technology Solutio (+$25M).
- Started 1 new stock position in Figure Technology Solutio.
- Reduced shares in these 1 stock: IOT.
- Sold out of its position in IOT.
- Lunate Capital was a net buyer of stock by $24M.
- Lunate Capital has $221M in assets under management (AUM), dropping by 23.95%.
- Central Index Key (CIK): 0002056786
Tip: Access up to 7 years of quarterly data
Positions held by Lunate Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Lunate Capital
Lunate Capital holds 6 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Revolution Medicines (RVMD) | 46.5 | $103M | 2.2M | 46.70 |
|
|
| Sailpoint (SAIL) | 30.0 | $66M | 3.0M | 22.08 |
|
|
| Figure Technology Solutio Com Cl A | 11.2 | $25M | NEW | 680k | 36.37 |
|
| Lineage (LINE) | 10.5 | $23M | 600k | 38.64 |
|
|
| Neumora Therapeutics (NMRA) | 1.8 | $3.9M | 2.1M | 1.82 |
|
|
| Revolution Medicines *w Exp 12/17/202 (RVMDW) | 0.1 | $135k | 450k | 0.30 |
|
Past Filings by Lunate Capital
SEC 13F filings are viewable for Lunate Capital going back to 2025
- Lunate Capital 2025 Q3 restated filed Nov. 20, 2025
- Lunate Capital 2025 Q2 filed July 17, 2025
- Lunate Capital 2025 Q1 filed April 25, 2025